3

3 Filing

Company: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Filed: September 3, 2015
Period of Report: September 3, 2015
Accession Number: 0001493152-15-004187

View Document ↗ View on SEC.gov ↗